December 4, 2017 03:27 PM EST
People
Financing

Michael Pelli­ni has just joined Bill Maris at Sec­tion 32 — fo­cused on pa­tient care and drug de­vel­op­ment

John Carroll

Editor & Founder

Michael Pelli­ni has just jumped in­to a se­nior role at one of the most in­trigu­ing new ven­ture funds in the bio­phar­ma/health­care world. The for­mer CEO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

ALX On­col­o­gy hires Genen­tech, Mi­rati vet as CMO; Af­ter Car­mot, Heather Turn­er has three new roles on tap

Evotec gains on Halozyme's takeover pro­pos­al

Arc In­sti­tute pub­lish­es new AI mod­el Evo, cre­at­ing CRISPR sys­tems in a leap for syn­thet­ic bi­ol­o­gy

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times